BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novartis Pharmaceutical Corporation 

150 Industrial Road

San Carlos  California  94070  U.S.A.
Phone: 650-622-1500 Fax: n/a


SEARCH JOBS



Novartis is a world leader in the research and development of products that protect and improve health and well-being. Our global mission is to discover, develop and successfully market innovative products to ease suffering and enhance the quality of life of our patients.

Novartis has been recognized for its admirable reputation, commitment to ethics, status as a respected pillar of the industry and for being an outstanding workplace for its employees. In recent years, we’ve been named among the “Most Admired” (FORTUNE & MedAdNews), “Most Innovative” (Fast Company), and “Most Ethical” (PharmaVoice) companies in the world. With global headquarters in Basel, Switzerland, and U.S. headquarters in East Hanover, New Jersey, the Novartis Group companies employ about 100,000 people and have a presence in more than 140 countries.

Our campus in San Carlos, just south of San Francisco, is part of Novartis Pharmaceuticals Corp. It is unique because it is home to both a Technical Research and Development site and a Pharmaceutical Operations commercial manufacturing site which combined employ 250+ people.

Our TRD site is focused on developing respiratory products for diseases such as cystic fibrosis, asthma and COPD. It incorporates drug development, process development, clinical manufacturing, inhalation device development, and proprietary equipment design. The site’s primary focus is particle engineering in which the facility pioneered the use of spray-drying technology.

Our Pharmaceutical Operations commercial manufacturing site produces an inhaled form of dry powder tobramycin for the TOBI Podhaler, which is used in the prevention of chronic lung infections in cystic fibrosis patients. It is approved for use in the United States, Canada, Europe and Saudi Arabia. The TOBI Podhaler not only gives patients a portable option for treatment, but also dramatically reduces their treatment time so they can live more independent lives.

San Carlos is a significant contributor to Novartis' growth in respiratory medicines, as well as continuing to actively support surrounding communities. We are constantly looking for the best and the brightest to join our talented team of scientists, engineers, operators, quality assurance and control, product development and support services. About one-quarter of the employees in San Carlos hold advanced science degrees. We offer a work environment that values innovation and the continuous pursuit of knowledge in order to provide the best products to our patients. Novartis offers a variety of competitive and comprehensive benefits for eligible full time employees.

To learn more about employment opportunities at the San Carlos Novartis site, visit www.novartis and click on "Careers." From there, go to "Job Search" and type "San Carlos" in the search bar.


 Key Statistics


Email:
Ownership: Public

Web Site: Novartis Pharmaceutical Corporation
Employees: 100,000 worldwide, 200 in San Carlos
Symbol: NVS
 



Industry
Pharmaceutical






 Company News
Novartis Pharmaceutical Corporation (NVS) AIN457 (secukinumab) Showed Significant Symptom Improvement In Two Pivotal Phase 3 ankylosing spondylitis Studies 11/17/2014 10:09:14 AM
Novartis Pharmaceutical Corporation (NVS) To Present First IL-17A Phase 3 Data For AIN457 (secukinumab) In Psoriatic Arthritis And Ankylosing Spondylitis At ACR 2014 11/10/2014 8:55:43 AM
Novartis Pharmaceutical Corporation (NVS) Release: U.S. Results From First Global Survey Of Neuroendocrine Tumor (NET) Patients Reveal Profound Impact Of This Rare Cancer On Quality Of Life 11/3/2014 9:17:26 AM
Novartis Pharmaceutical Corporation (NVS) Teams Up With Multiple Sclerosis Advocate And Musician David Osmond To Launch MS Education Initiative Our Voice In Song™ 10/21/2014 8:13:34 AM
SCRS Announces Novartis Pharmaceutical Corporation (NVS) and Quintiles, Inc. (QTRN) as Winners of the 2013 Eagle Awards 10/15/2013 9:15:15 AM
AstraZeneca PLC (AZN), Pfizer Inc. (PFE), Novartis (NVS) Among Suitors for Onyx Pharmaceuticals, Inc. (ONXX) 7/23/2013 11:00:04 AM
Novartis AG (NVS) Chief Touts "Industry-Best" Biosimilars 7/18/2013 7:46:59 AM
Feds Probe Novartis AG (NVS) Over Marketing of Its Gilenya MS Pill 7/18/2013 7:23:14 AM
UK Health Watchdog Doesn't Recommend Novartis AG (NVS)'s Afinitor 7/8/2013 8:05:50 AM
Novartis (NVS) Heart Drug Gets FDA's "Breakthrough" Status 6/21/2013 8:01:40 AM
123